| [1] |
Zhang Y, Zhou X, Huang P. Fanconi anemia and ubiquitination [J]. J Genet Genomics, 2007, 34(7): 573-580.
|
| [2] |
Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia [J]. Nat Rev Genet, 2001, 2(6): 446-457.
|
| [3] |
Rosenberg PS, Tamary H, Alter BP. How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi anemia in the United States and Israel [J]. Am J Med Genet A, 2011, 155A(8): 1877-1883.
|
| [4] |
张莹莹，吴占河．范可尼贫血的新概念和临床与实验室诊断[J]．诊断学理论与实践，2013, 12 (5):501-503.
|
| [5] |
Río P, Navarro S, Bueren JA. Advances in gene therapy for Fanconi anemia [J]. Hum Gene Ther, 2018, 29(10): 1114-1123.
|
| [6] |
Li N, Ding L, Li B, et al. Functional analysis of Fanconi anemia mutations in China [J]. Exp Hematol, 2018, 66: 32-41.e8.
|
| [7] |
陈飞，张克俭. 第18届国际范可尼贫血学术会议简介[J]. 中华血液学杂志，2007，28(4):281.
|
| [8] |
Gross M, Hanenberg H, Lobitz S, et al. Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction [J]. Cytogenet Genome Res, 2002, 98(2-3): 126-135.
|
| [9] |
Asur RS, Kimble DC, Lach FP, et al. Somatic mosaicism of an intragenic FANCB duplication in both fibroblast and peripheral blood cells observed in a Fanconi anemia patient leads to milder phenotype [J]. Mol Genet Genomic Med, 2018, 6(1): 77-91.
|
| [10] |
Mankad A, Taniguchi T, Cox B, et al. Natural gene therapy in monozygotic twins with Fanconi anemia [J]. Blood, 2006, 107(8): 3084-3090.
|
| [11] |
Gregory JJ Jr, Wagner JE, Verlander PC, et al. Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells [J]. Proc Natl Acad Sci U S A, 2001, 98(5): 2532-2537.
|
| [12] |
Minton K. Inflammation：inflammatory pathology of Fanconi anaemia [J]. Nat Rev Immunol, 2016, 16(6): 336-337.
|
| [13] |
Ceccaldi R, Sarangi P, D′Andrea AD. The Fanconi anaemia pathway: new players and new functions [J]. Nat Rev Mol Cell Biol, 2016, 17(6): 337-349.
|
| [14] |
Sumpter R Jr, Sirasanagandla S, Fernández ÁF, et al. Fanconi anemia proteins function in mitophagy and immunity [J]. Cell, 2016, 165(4): 867-881.
|
| [15] |
Sumpter R, Levine B. Novel functions of Fanconi anemia proteins in selective autophagy and inflammation [J]. Oncotarget, 2016, 7(32): 50820-50821.
|
| [16] |
Roxo P Jr, Arruda LK, Nagao AT, et al. Allergic and immunologic parameters in patients with Fanconi′s anemia [J]. Int Arch Allergy Immunol, 2001, 125(4): 349-355.
|
| [17] |
Myers KC, Bleesing JJ, Davies SM, et al. Impaired immune function in children with Fanconi anaemia [J]. Br J Haematol, 2011, 154(2): 234-240.
|
| [18] |
Myers KC, Sauter S, Zhang X, et al. Impaired immune function in children and adults with Fanconi anemia [J]. Pediatr Blood Cancer, 2017, 64(11): e 26599.
|
| [19] |
Justo GA, Bitencourt MA, Pasquini R, et al. Immune status of Fanconi anemia patients: decrease in T CD8 and CD56dim CD16＋ NK lymphocytes [J]. Ann Hematol, 2014, 93(5): 761-767.
|
| [20] |
Sekinaka Y, Mitsuiki N, Imai K, et al. Common variable immunodeficiency caused by FANC mutations [J]. J Clin Immunol, 2017, 37(5): 434-444.
|
| [21] |
Giri N, Alter BP, Penrose K, et al. Immune status of patients with inherited bone marrow failure syndromes [J]. Am J Hematol, 2015, 90(8): 702-708.
|
| [22] |
Neveling K, Endt D, Hoehn H, et al. Genotype-phenotype correlations in Fanconi anemia [J]. Mutat Res, 2009, 668(1-2): 73-91.
|
| [23] |
尹延珂．范可尼贫血临床特征的新认识[J]．国际儿科学杂志，2010，37(5):490-493.
|
| [24] |
Johnson-Tesch BA, Gawande RS, Zhang L, et al. Fanconi anemia: correlating central nervous system malformations and genetic complementation groups [J]. Pediatr Radiol, 2017, 47(7): 868-876.
|
| [25] |
Brosh RM Jr, Bellani M, Liu Y, et al. Fanconi anemia: a DNA repair disorder characterized by accelerated decline of the hematopoietic stem cell compartment and other features of aging [J]. Ageing Res Rev, 2017, 33: 67-75.
|
| [26] |
Ebens CL, DeFor TE, Tryon R, et al. Comparable outcomes after HLA-matched sibling and alternative donor hematopoietic cell transplantation for children with Fanconi anemia and severe aplastic anemia [J]. Biol Blood Marrow Transplant, 2018, 24(4): 765-771.
|
| [27] |
Meyer S, Tischkowitz M, Chandler K, et al. Fanconi anaemia, BRCA2 mutations and childhood cancer: a developmental perspective from clinical and epidemiological observations with implications for genetic counselling [J]. J Med Genet, 2014, 51(2): 71-75.
|
| [28] |
Haude K, McCarthy Veach P, et al. Factors influencing the decision-making process and long-term interpersonal outcomes for parents who undergo preimplantation genetic diagnosis for Fanconi anemia: a qualitative investigation [J]. J Genet Couns, 2017, 26(3): 640-655.
|
| [29] |
Shim YJ, Kim HS, Do YR, et al. Sequential strategy for umbilical cord blood transplantation in a Korean Fanconi anemia girl with refractory acute myelomonocytic leukemia and complex karyotype [J]. Pediatr Transplant, 2017, 21(2): 12871.
|
| [30] |
Ayas MF, Al-Seraihi A, Al-Agil A, et al. Successful hematopoietic cell transplantation in Fanconi anemia patients with renal impairment using ultra-reduced doses of cyclophosphamide and fludarabine [J]. Pediatr Blood Cancer, 2018, 65(12): e27371.
|
| [31] |
Talbot A, Peffault de Latour R, et al. Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia [J]. Haematologica, 2014, 99(10): e199-e200.
|
| [32] |
Antonio Casado J, Callén E, Jacome A, et al. A comprehensive strategy for the subtyping of patients with Fanconi anaemia: conclusions from the Spanish Fanconi Anemia Research Network [J]. J Med Genet, 2007, 44(4): 241-249.
|